Zalka is a 28 year long fellow of the American Academy of Dermatology, as well as the Dermatologic Surgery Society and the Connecticut State Dermatology and Dermatologic Surgery Society, where she also served as a past president
The approval followed the largest longitudinal study through the STEP (Semaglutide Treatment Effect in People with Obesity) program
These reports align with the broader clinical literature on semaglutide tolerability
This study reports that people who are more interested in GLP-1 medications and more willing to tolerate its negative side effects have higher levels of body dissatisfaction and shame, more bias against fat people, and more disordered eating behaviors
Call your doctor: If you experience any of these rare side effects and they don't go away or get worse, it's important to call your doctor for further evaluation
"Oana-affiliated medical practices are independently owned and operated by licensed physicians who provide services using the Oana telehealth platform" [1]